Investors Research Corp Invests $63,000 in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Investors Research Corp purchased a new position in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) in the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 35,950 shares of the company’s stock, valued at approximately $63,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Renaissance Technologies LLC lifted its holdings in Stereotaxis by 1,006.9% during the 2nd quarter. Renaissance Technologies LLC now owns 798,100 shares of the company’s stock worth $1,469,000 after purchasing an additional 726,000 shares in the last quarter. Lagoda Investment Management L.P. lifted its holdings in Stereotaxis by 13.6% during the 4th quarter. Lagoda Investment Management L.P. now owns 2,492,665 shares of the company’s stock worth $5,160,000 after purchasing an additional 297,725 shares in the last quarter. Millennium Management LLC lifted its holdings in Stereotaxis by 47.8% during the 2nd quarter. Millennium Management LLC now owns 893,962 shares of the company’s stock worth $1,645,000 after purchasing an additional 289,012 shares in the last quarter. Legato Capital Management LLC lifted its holdings in Stereotaxis by 90.4% during the 2nd quarter. Legato Capital Management LLC now owns 494,723 shares of the company’s stock worth $757,000 after purchasing an additional 234,833 shares in the last quarter. Finally, Verition Fund Management LLC lifted its holdings in Stereotaxis by 333.2% during the 1st quarter. Verition Fund Management LLC now owns 129,946 shares of the company’s stock worth $485,000 after purchasing an additional 99,946 shares in the last quarter. Institutional investors own 45.35% of the company’s stock.

Stereotaxis Stock Performance

NYSEAMERICAN:STXS opened at $2.64 on Wednesday. Stereotaxis, Inc. has a twelve month low of $1.33 and a twelve month high of $3.29.

Stereotaxis (NYSEAMERICAN:STXS) last released its quarterly earnings results on Monday, March 4th. The company reported ($0.07) earnings per share for the quarter, meeting the consensus estimate of ($0.07). Stereotaxis had a negative return on equity of 103.37% and a negative net margin of 77.37%. The firm had revenue of $4.57 million for the quarter, compared to analysts’ expectations of $7.55 million. Sell-side analysts predict that Stereotaxis, Inc. will post -0.23 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Lake Street Capital increased their price objective on Stereotaxis from $3.00 to $4.00 and gave the stock a “buy” rating in a report on Tuesday, March 5th. Roth Mkm reaffirmed a “buy” rating and issued a $5.00 price target on shares of Stereotaxis in a report on Tuesday, March 5th.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.